208 related articles for article (PubMed ID: 12369608)
1. Pharmacology and pharmacokinetics of milnacipran.
Puozzo C; Panconi E; Deprez D
Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S25-35. PubMed ID: 12369608
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics and drug interactions of antidepressive agents].
Sawada Y; Ohtani H
Nihon Rinsho; 2001 Aug; 59(8):1539-45. PubMed ID: 11519155
[TBL] [Abstract][Full Text] [Related]
3. Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain.
Leo RJ; Brooks VL
Curr Opin Investig Drugs; 2006 Jul; 7(7):637-42. PubMed ID: 16869117
[TBL] [Abstract][Full Text] [Related]
4. Preclinical pharmacology of milnacipran.
Briley M; Prost JF; Moret C
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():9-14. PubMed ID: 8923122
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of milnacipran in comparison with other antidepressants.
Puozzo C; Leonard BE
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():15-27. PubMed ID: 8923123
[TBL] [Abstract][Full Text] [Related]
6. Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?
Wong DT; Bymaster FP
Prog Drug Res; 2002; 58():169-222. PubMed ID: 12079200
[TBL] [Abstract][Full Text] [Related]
7. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
Ishigooka J
Nihon Rinsho; 2001 Aug; 59(8):1523-9. PubMed ID: 11519152
[TBL] [Abstract][Full Text] [Related]
8. Japanese experience with dual-action antidepressants.
Tajima O
Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S37-42. PubMed ID: 12369609
[TBL] [Abstract][Full Text] [Related]
9. Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.
Yoshida K; Takahashi H; Higuchi H; Kamata M; Ito K; Sato K; Naito S; Shimizu T; Itoh K; Inoue K; Suzuki T; Nemeroff CB
Am J Psychiatry; 2004 Sep; 161(9):1575-80. PubMed ID: 15337646
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics and drug interaction of antidepressants and anti-manic drugs].
Suzuki K; Koyama T
Ryoikibetsu Shokogun Shirizu; 2003; (38):366-9. PubMed ID: 12877004
[No Abstract] [Full Text] [Related]
11. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability.
Puech A; Montgomery SA; Prost JF; Solles A; Briley M
Int Clin Psychopharmacol; 1997 Mar; 12(2):99-108. PubMed ID: 9219045
[TBL] [Abstract][Full Text] [Related]
12. [Depression and pain: novel clinical, neurobiological and psychopharmacological data].
Jaracz J; Rybakowski J
Psychiatr Pol; 2005; 39(5):937-50. PubMed ID: 16358593
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of milnacipran: an overview.
Montgomery SA; Prost JF; Solles A; Briley M
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():47-51. PubMed ID: 8923127
[TBL] [Abstract][Full Text] [Related]
14. Milnacipran. A review of its use in depression.
Spencer CM; Wilde MI
Drugs; 1998 Sep; 56(3):405-27. PubMed ID: 9777315
[TBL] [Abstract][Full Text] [Related]
15. Milnacipran and selective serotonin reuptake inhibitors in major depression.
Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine.
Gervasoni D; Panconi E; Henninot V; Boissard R; Barbagli B; Fort P; Luppi PH
Pharmacol Biochem Behav; 2002 Oct; 73(3):557-63. PubMed ID: 12151030
[TBL] [Abstract][Full Text] [Related]
17. ACS chemical neuroscience molecule spotlight on savella.
Hopkins CR
ACS Chem Neurosci; 2010 May; 1(5):345. PubMed ID: 22778830
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications.
Caccia S
Clin Pharmacokinet; 1998 Apr; 34(4):281-302. PubMed ID: 9571301
[TBL] [Abstract][Full Text] [Related]
19. Milnacipran: beyond a role of antidepressant.
Pae CU; Marks DM; Shah M; Han C; Ham BJ; Patkar AA; Masand PS
Clin Neuropharmacol; 2009; 32(6):355-63. PubMed ID: 19620845
[TBL] [Abstract][Full Text] [Related]
20. Dual action antidepressants and some important considerations.
Gupta RK; Tiller JW; Burrows GD
Aust N Z J Psychiatry; 2003 Apr; 37(2):190-5. PubMed ID: 12656958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]